These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 18539482

  • 1. A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge.
    Wang T, Qi Z, Wu B, Zhu Z, Yang Y, Cui B, Dai R, Zhang Q, Qiu Y, Wang Z, Wang H, Guo Z, Wang X, Yang R.
    Protein Expr Purif; 2008 Sep; 61(1):7-12. PubMed ID: 18539482
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.
    Powell BS, Andrews GP, Enama JT, Jendrek S, Bolt C, Worsham P, Pullen JK, Ribot W, Hines H, Smith L, Heath DG, Adamovicz JJ.
    Biotechnol Prog; 2005 Sep; 21(5):1490-510. PubMed ID: 16209555
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunochemical localization of the fraction-1 antigen, a virulence determinant of Yersinia pestis.
    Abath FG, Almeida AM, Ferreira LC.
    An Acad Bras Cienc; 1990 Sep; 62(3):291-7. PubMed ID: 2094179
    [Abstract] [Full Text] [Related]

  • 6. Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice.
    Little SF, Webster WM, Wilhelm H, Fisher D, Norris SL, Powell BS, Enama J, Adamovicz JJ.
    Vaccine; 2010 Jan 22; 28(4):934-9. PubMed ID: 19925906
    [Abstract] [Full Text] [Related]

  • 7. Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.
    Goodin JL, Nellis DF, Powell BS, Vyas VV, Enama JT, Wang LC, Clark PK, Giardina SL, Adamovicz JJ, Michiel DF.
    Protein Expr Purif; 2007 May 22; 53(1):63-79. PubMed ID: 17293124
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of outer membrane proteins of Yersinia pestis and Yersinia pseudotuberculosis strains isolated from India.
    Khushiramani R, Tuteja U, Shukla J, Batra HV.
    Indian J Exp Biol; 2004 May 22; 42(5):508-14. PubMed ID: 15233478
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunisation against plague by transcutaneous and intradermal application of subunit antigens.
    Eyles JE, Elvin SJ, Westwood A, Lebutt CS, Alpar HO, Somavarapu S, Williamson ED.
    Vaccine; 2004 Oct 22; 22(31-32):4365-73. PubMed ID: 15474730
    [Abstract] [Full Text] [Related]

  • 14. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE, Butcher WA, Titball RW, Hill J.
    Vaccine; 2007 Oct 16; 25(42):7301-6. PubMed ID: 17869388
    [Abstract] [Full Text] [Related]

  • 15. Detection and isolation of Yersinia pestis without fraction 1 antigen by monoclonal antibody in foods and water.
    Zhao T, Zhao P, Doyle MP.
    J Food Prot; 2012 Sep 16; 75(9):1555-61. PubMed ID: 22947461
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity.
    Schmidt A, Schaffelhofer S, Müller K, Röllinghoff M, Beuscher HU.
    Microb Pathog; 1999 Apr 16; 26(4):221-33. PubMed ID: 10089162
    [Abstract] [Full Text] [Related]

  • 17. Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis.
    Weeks S, Hill J, Friedlander A, Welkos S.
    Microb Pathog; 2002 May 16; 32(5):227-37. PubMed ID: 12071679
    [Abstract] [Full Text] [Related]

  • 18. Small protective fragments of the Yersinia pestis V antigen.
    Vernazza C, Lingard B, Flick-Smith HC, Baillie LW, Hill J, Atkins HS.
    Vaccine; 2009 May 11; 27(21):2775-80. PubMed ID: 19366573
    [Abstract] [Full Text] [Related]

  • 19. Failure of intragastrically administered Yersinia pestis capsular antigen to protect mice against challenge with virulent plague: suppression of fraction 1-specific antibody response.
    Thomas RE, Simpson WJ, Perry LL, Schwan TG.
    Am J Trop Med Hyg; 1992 Jul 11; 47(1):92-7. PubMed ID: 1386197
    [Abstract] [Full Text] [Related]

  • 20. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis.
    Khan AA, Babu JP, Gupta G, Rao DN.
    Vaccine; 2008 Jan 17; 26(3):316-32. PubMed ID: 18096277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.